Pure Global
NCT06040697

Formative Usability Assessment of Wireless Thermal Anisotropy Devices

Formative Usability Assessment of Wireless Thermal Anisotropy Devices Measuring Flow in Cerebrospinal Fluid Shunts
Rhaeos, Inc.·ClinicalTrials.gov·device·Device trialRecruiting
View on ClinicalTrials.gov →
Study focus
Disease/Condition
Hydrocephalus
Drug/Device/Intervention
Thermal Anisotropy
Study type
Observational
Intervention type
device
Sponsor & location
Primary sponsor
Rhaeos, Inc.
Location
Chicago, United States of America
Timeline & enrollment
Phase
N/A
Start date
Sep 29, 2023
End date
Apr 01, 2024
Enrollment
145 participants
Primary outcome

Exploratory device usability feedback

Summary

Measurements of shunt flow will be performed non-invasively. This study will generate
 usability data via observed tasks and comprehension questions to enable future device design
 improvements.

ICD-10 classifications
HydrocephalusHydrocephalus, unspecifiedOther hydrocephalusCongenital hydrocephalusObstructive hydrocephalus
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06040697
Type
Device Trial
About this record

Access comprehensive clinical trial information for NCT06040697 through Pure Global AI's free database. This phase not specified trial is sponsored by Rhaeos, Inc. and is currently Recruiting. The study focuses on Hydrocephalus. Target enrollment is 145 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.